Cargando…

Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer

BACKGROUND: The role of postoperative external beam radiotherapy (EBRT) in patients with residual iodine refractory-differentiated thyroid cancer (IR-DTC) is still inconclusive. The aim of this retrospective study was to evaluate locoregional control (LRC) and overall survival (OS), and potential si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groen, Andries H, van Dijk, Deborah, Sluiter, Wim, Links, Thera P, Bijl, Hendrik P, Plukker, John T M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142801/ https://www.ncbi.nlm.nih.gov/pubmed/34981752 http://dx.doi.org/10.1530/ETJ-21-0033

Ejemplares similares

The outcome of treatment in differentiated thyroid cancer according to recommendations in current Dutch and American guidelines
por: van Dijk, Deborah, et al.
Publicado: (2022)

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
por: Sondorp, Luc H.J., et al.
Publicado: (2020)

A Sensitive Tg Assay or rhTSH Stimulated Tg: What's the Best in the Long-Term Follow-Up of Patients with Differentiated Thyroid Carcinoma?
por: Persoon, Adrienne C.M., et al.
Publicado: (2007)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

Surgical Complications and Referral Patterns in 567 Patients with Differentiated Thyroid Cancer in the Northern Region of the Netherlands: A Population-Based Study Towards Clinical Management Implementation
por: van Dijk, Deborah, et al.
Publicado: (2020)

The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
por: Kim, Tae Hyun, et al.
Publicado: (2010)

Generation and Differentiation of Adult Tissue-Derived Human Thyroid Organoids
por: Ogundipe, Vivian M.L., et al.
Publicado: (2021)

Onset of hypothyroidism after total laryngectomy: Effects of thyroid gland surgery and preoperative and postoperative radiotherapy
por: Plaat, Robert E., et al.
Publicado: (2019)

The diagnostic value of (124)I-PET in patients with differentiated thyroid cancer
por: Phan, Ha T. T., et al.
Publicado: (2008)

(18)F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study
por: Farina, Eleonora, et al.
Publicado: (2017)

Low-Iodine Diet of 4 Days Is Sufficient Preparation for (131)I Therapy in Differentiated Thyroid Cancer Patients
por: Dekker, Bernadette L, et al.
Publicado: (2021)

Letter to the Editor From Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Zandee, Wouter T, et al.
Publicado: (2023)

Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2015)

Combined Effect of Iodine Contrast Media, Cisplatin and External Beam Radiotherapy on Anaplastic Thyroid Cancer Cells
por: Nadi, S., et al.
Publicado: (2019)

Use of Salivary Iodine Concentrations to Estimate the Iodine Status of Adults in Clinical Practice
por: Dekker, Bernadette L, et al.
Publicado: (2021)

Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer
por: Kwon, Jeanny, et al.
Publicado: (2013)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis
por: Servagi Vernat, Stéphanie, et al.
Publicado: (2019)

Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer
por: Links, Thera P, et al.
Publicado: (2020)

Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)
por: Lutgers, Helen L., et al.
Publicado: (2009)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Postoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer
por: Im, Jung Ho, et al.
Publicado: (2014)

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy
por: Bayoumi, Yasser, et al.
Publicado: (2014)

Locoregional Disease Control After External Beam Radiotherapy in 91 Patients with Differentiated Thyroid Carcinoma and pT4 Tumor Stage - A Single Institution Experience
por: Besic, Nikola, et al.
Publicado: (2018)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine‐refractory differentiated thyroid cancer
por: Berciano‐Guerrero, Miguel‐Ángel
Publicado: (2022)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
por: Wong, Selina K., et al.
Publicado: (2019)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
por: Haciislamoglu, Emel, et al.
Publicado: (2019)

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
por: Meerwaldt, Robbert, et al.
Publicado: (2008)

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
por: Fordham, Beth A, et al.
Publicado: (2015)

Effect of monocarboxylate transporter-1 on the biological behavior of iodine-refractory thyroid carcinoma
por: Li, Qian, et al.
Publicado: (2021)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer
por: Kim, Eunji, et al.
Publicado: (2017)

The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019)

Long-Term Locoregional Vascular Morbidity After Isolated Limb Perfusion and External-Beam Radiotherapy for Soft Tissue Sarcoma of the Extremity
por: Hoven-Gondrie, Miriam L., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tj0300p4gc751d3mgctiqm86if